Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2016

01-05-2016 | original article

Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD)

Authors: Federica Montagnese, Francesca Granata, Olimpia Musumeci, Carmelo Rodolico, Stefania Mondello, Emanuele Barca, Maria Cucinotta, Anna Ciranni, Marcello Longo, Antonio Toscano

Published in: Journal of Inherited Metabolic Disease | Issue 3/2016

Login to get access

Abstract

Background and objectives

Pompe disease is a rare metabolic disorder due to lysosomal alpha-glucosidase (GAA) deficiency. It is considered as a multi-systemic disease since, although glycogen accumulation is largely prominent in heart, skeletal and respiratory muscles, other organs can also be affected. As regards the vascular system, few reports have documented cerebrovascular malformations in Pompe patients. The aim of this study was to define the presence and type of intracranial arterial abnormalities in a cohort of late onset Pompe disease (LOPD) patients.

Methods

We have studied 21 LOPD patients with cerebral CT angiography (CTA), using maximum intensity projection and volume rendering technique for 3D-image reconstruction.

Results

We found intracranial arterial abnormalities in 13/21 patients (62 %), of whom: 2/21 patients (9.5 %) showed an unruptured intracranial aneurysm (respectively 2 and 4 mm), 10/21 (47 %) had a vertebrobasilar dolichoectasia (VBD) and 1/21 a basilar artery fenestration. Signs of lacunar encephalopathy (insular, capsular and frontal subcortical lesions) were detected in 13/21 patients (62 %) and this correlated with the presence of respiratory impairment (p = 0.017).

Conclusions

These findings differ from what has been previously observed in healthy, aged-matched populations and confirm that cerebral arteries abnormalities, mainly involving the posterior circle, are not so rare in LOPD patients and are often accompanied by a lacunar encephalopathy that might represent a hypoxic-ischemic origin. A CTA or an MRA is recommended, in LOPD patients, for early detection of cerebrovascular malformations as they could lead to life-threatening events such as sub-arachnoid haemorrhage or brainstem compression.
Literature
go back to reference Anneser JM, Pongratz DE, Podskarbi T, Shin YS, Schoser BG (2005) Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype. Neurology 64:368–70CrossRefPubMed Anneser JM, Pongratz DE, Podskarbi T, Shin YS, Schoser BG (2005) Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype. Neurology 64:368–70CrossRefPubMed
go back to reference Bertoldo F, Zappini F, Brigo M et al (2015) Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. J Clin Endocrinol Metab 100:401–6CrossRefPubMed Bertoldo F, Zappini F, Brigo M et al (2015) Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. J Clin Endocrinol Metab 100:401–6CrossRefPubMed
go back to reference Brown RD, Broderick JP (2014) Unrupted intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol 13:393–404CrossRefPubMed Brown RD, Broderick JP (2014) Unrupted intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol 13:393–404CrossRefPubMed
go back to reference DeRuisseau LR, Fuller DD, Qiu K et al (2009) Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A 106:9419–24CrossRefPubMedPubMedCentral DeRuisseau LR, Fuller DD, Qiu K et al (2009) Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A 106:9419–24CrossRefPubMedPubMedCentral
go back to reference Förster A, Ssozi J, Al-Zghloul M, Brockmann MA, Kerl HU, Groden C (2014) A comparison of CT/CT angiography and MRI/MR angiography for imaging of vertebrobasilar dolichoectasia. Clin Neuroradiol 24(4):347–53CrossRefPubMed Förster A, Ssozi J, Al-Zghloul M, Brockmann MA, Kerl HU, Groden C (2014) A comparison of CT/CT angiography and MRI/MR angiography for imaging of vertebrobasilar dolichoectasia. Clin Neuroradiol 24(4):347–53CrossRefPubMed
go back to reference Gaeta M, Barca E, Ruggeri P et al (2013) A late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab 110:290–6 Gaeta M, Barca E, Ruggeri P et al (2013) A late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab 110:290–6
go back to reference Gutierrez J, Bagci A, Gardener H et al (2014) Dolichoectasia diagnostic methods in a multi-ethnic, stroke-free cohort: results from the Northern Manhattan Study. J Neuroimaging 24:226–31CrossRefPubMed Gutierrez J, Bagci A, Gardener H et al (2014) Dolichoectasia diagnostic methods in a multi-ethnic, stroke-free cohort: results from the Northern Manhattan Study. J Neuroimaging 24:226–31CrossRefPubMed
go back to reference Hensel O, Hanisch F, Stock K et al (2015) Morphology and function of cerebral arteries in adults with pompe. Dis JIMD Rep 20:27–33CrossRef Hensel O, Hanisch F, Stock K et al (2015) Morphology and function of cerebral arteries in adults with pompe. Dis JIMD Rep 20:27–33CrossRef
go back to reference Hobson-Webb LD, Proia AD, Thurberg BL et al (2012) Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab 106:462–9CrossRefPubMed Hobson-Webb LD, Proia AD, Thurberg BL et al (2012) Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab 106:462–9CrossRefPubMed
go back to reference Kanters TA, Hoogenboom-Plug I, Rutten-Van Mölken MP et al (2014) Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease. Orphanet J Rare Dis 9:75CrossRefPubMedPubMedCentral Kanters TA, Hoogenboom-Plug I, Rutten-Van Mölken MP et al (2014) Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease. Orphanet J Rare Dis 9:75CrossRefPubMedPubMedCentral
go back to reference Kapsalaki EZ, Rountas CD, Fountas KN (2012) The role of 3 tesla MRA in the detection of intracranial aneurysms. Int J Vasc Med 2012:792–834 Kapsalaki EZ, Rountas CD, Fountas KN (2012) The role of 3 tesla MRA in the detection of intracranial aneurysms. Int J Vasc Med 2012:792–834
go back to reference Karabul N, Skudlarek A, Berndt J, Kornblum C, Kley RA, Wenninger S, Tiling N, Mengel E, Plöckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F (2014) Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectionalsurvey. JIMD Rep 17:53–61CrossRefPubMedPubMedCentral Karabul N, Skudlarek A, Berndt J, Kornblum C, Kley RA, Wenninger S, Tiling N, Mengel E, Plöckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F (2014) Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectionalsurvey. JIMD Rep 17:53–61CrossRefPubMedPubMedCentral
go back to reference Komotar RJ, Mocco J, Solomon RA (2008) Guidelines for the surgical treatment of unruptured intracranial aneurysms: the first annual J. Lawrence pool memorial research symposium—controversies in the management of cerebral aneurysms. Neurosurgery 62:183–93, discussion 193–4 Komotar RJ, Mocco J, Solomon RA (2008) Guidelines for the surgical treatment of unruptured intracranial aneurysms: the first annual J. Lawrence pool memorial research symposium—controversies in the management of cerebral aneurysms. Neurosurgery 62:183–93, discussion 193–4
go back to reference Kretzschmar HA, Wagner H, Hübner G et al (1990) Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency. J Neurol Sci 98:169–83CrossRefPubMed Kretzschmar HA, Wagner H, Hübner G et al (1990) Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency. J Neurol Sci 98:169–83CrossRefPubMed
go back to reference Kumral E, Kisabay A, Ataç C et al (2005) The mechanism of ischemic stroke in patients with dolichoectatic basilar artery. Eur J Neurol 12:437–44CrossRefPubMed Kumral E, Kisabay A, Ataç C et al (2005) The mechanism of ischemic stroke in patients with dolichoectatic basilar artery. Eur J Neurol 12:437–44CrossRefPubMed
go back to reference Laforêt P, Petiot P, Nicolino M et al (2008) Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 70(22):2063–6CrossRefPubMed Laforêt P, Petiot P, Nicolino M et al (2008) Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 70(22):2063–6CrossRefPubMed
go back to reference Laforêt P, Laloui K, Granger B, The French Pompe registry et al (2013) Baseline characteristics of a cohort of 126 patients with adult Pompe disease. Rev Neurol (Paris) 169(8–9):595–602CrossRef Laforêt P, Laloui K, Granger B, The French Pompe registry et al (2013) Baseline characteristics of a cohort of 126 patients with adult Pompe disease. Rev Neurol (Paris) 169(8–9):595–602CrossRef
go back to reference Mellies U, Lofaso F (2009) Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med 103:477–84CrossRefPubMed Mellies U, Lofaso F (2009) Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med 103:477–84CrossRefPubMed
go back to reference Montagnese F, Barca E, Musumeci O et al (2015) Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment. J Neurol 262:968–78CrossRefPubMed Montagnese F, Barca E, Musumeci O et al (2015) Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment. J Neurol 262:968–78CrossRefPubMed
go back to reference Musumeci O, Catalano N, Barca E et al (2012) Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients. Mol Genet Metab 107:480–4CrossRefPubMed Musumeci O, Catalano N, Barca E et al (2012) Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients. Mol Genet Metab 107:480–4CrossRefPubMed
go back to reference Pizza F, Biallas M, Wolf M et al (2010) Nocturnal cerebral hemodynamics in snorers and in patients with obstructive sleep apnea: a near-infrared spectroscopy study. Sleep 33:205–10CrossRefPubMedPubMedCentral Pizza F, Biallas M, Wolf M et al (2010) Nocturnal cerebral hemodynamics in snorers and in patients with obstructive sleep apnea: a near-infrared spectroscopy study. Sleep 33:205–10CrossRefPubMedPubMedCentral
go back to reference Remiche G, Herbaut AG, Ronchi D et al (2012) Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition. Eur Neurol 68:75–8CrossRefPubMed Remiche G, Herbaut AG, Ronchi D et al (2012) Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition. Eur Neurol 68:75–8CrossRefPubMed
go back to reference Sacconi S, Bocquet JD, Chanalet S, Tanant V, Salviati L (2010) Desnuelle C abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 257:1730–3 Sacconi S, Bocquet JD, Chanalet S, Tanant V, Salviati L (2010) Desnuelle C abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 257:1730–3
go back to reference Schüller A, Wenninger S, Strigl-Pill N et al (2012) Toward deconstructing the phenotype of late-onset Pompe disease. Am J Med Genet C Semin Med Genet 160C:80–8CrossRefPubMed Schüller A, Wenninger S, Strigl-Pill N et al (2012) Toward deconstructing the phenotype of late-onset Pompe disease. Am J Med Genet C Semin Med Genet 160C:80–8CrossRefPubMed
go back to reference Sogawa K, Kikuchi Y, O’uchi T et al (2013) Fenestrations of the basilar artery demonstrated on magnetic resonance angiograms: an analysis of 212 cases. Interv Neuroradiol 19:461–5CrossRefPubMedPubMedCentral Sogawa K, Kikuchi Y, O’uchi T et al (2013) Fenestrations of the basilar artery demonstrated on magnetic resonance angiograms: an analysis of 212 cases. Interv Neuroradiol 19:461–5CrossRefPubMedPubMedCentral
go back to reference Tanaka M, Sakaguchi M, Miwa K et al (2013) Basilar artery diameter is an independent predictor of incident cardiovascular events. Arterioscler Thromb Vasc Biol 33:2240–4CrossRefPubMed Tanaka M, Sakaguchi M, Miwa K et al (2013) Basilar artery diameter is an independent predictor of incident cardiovascular events. Arterioscler Thromb Vasc Biol 33:2240–4CrossRefPubMed
go back to reference Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951–9CrossRefPubMed Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951–9CrossRefPubMed
go back to reference Vlak MH, Algra A, Branderburg R et al (2011) Prevalence of unrupted intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 10:595–7CrossRef Vlak MH, Algra A, Branderburg R et al (2011) Prevalence of unrupted intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 10:595–7CrossRef
go back to reference Wiebers DO (2006) Unruptured intracranial aneurysms: natural history and clinical management. Update on the international study of unruptured intracranial aneurysms. Neuroimaging Clin N Am 16:383–390CrossRefPubMed Wiebers DO (2006) Unruptured intracranial aneurysms: natural history and clinical management. Update on the international study of unruptured intracranial aneurysms. Neuroimaging Clin N Am 16:383–390CrossRefPubMed
Metadata
Title
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD)
Authors
Federica Montagnese
Francesca Granata
Olimpia Musumeci
Carmelo Rodolico
Stefania Mondello
Emanuele Barca
Maria Cucinotta
Anna Ciranni
Marcello Longo
Antonio Toscano
Publication date
01-05-2016
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2016
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9913-x

Other articles of this Issue 3/2016

Journal of Inherited Metabolic Disease 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.